TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3028% below fair value
$94.02−2.41 (-2.50%)
Close on Nov 19, 2026Market cap $3.26BP/E 24.4Yield 0.00%
TransMedics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
TransMedics's free cash flow for the twelve months ending Jun 30, 2026 was $79.04M, up 355.5% year over year. For fiscal 2025 it was $133.59M. The highest annual figure on record is $133.59M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $133.59M | – |
| FY2024 | Dec 31, 2024 | -$80.94M | – |
| FY2023 | Dec 31, 2023 | -$164.88M | – |
| FY2022 | Dec 31, 2022 | -$57.72M | – |
| FY2021 | Dec 31, 2021 | -$32.38M | – |
| FY2020 | Dec 31, 2020 | -$30.72M | – |
| FY2019 | Dec 28, 2019 | -$32.45M | – |
| FY2018 | Dec 29, 2018 | -$26.40M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.22M | -87.6% |
| Q1 FY2026 | Mar 31, 2026 | -$12.12M | – |
| Q4 FY2025 | Dec 31, 2025 | $19.00M | +213.7% |
| Q3 FY2025 | Sep 30, 2025 | $61.95M | – |
| Q2 FY2025 | Jun 30, 2025 | $82.53M | +4121.7% |
| Q1 FY2025 | Mar 31, 2025 | -$29.89M | – |
| Q4 FY2024 | Dec 31, 2024 | $6.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$41.35M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$47.61M | – |
| Q4 FY2023 | Dec 31, 2023 | -$33.51M | – |
| Q3 FY2023 | Sep 30, 2023 | -$114.59M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.18M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.59M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.80M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.21M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.35M | – |
| Q1 FY2022 | Mar 31, 2022 | -$20.36M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.83M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.42M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.79M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.35M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.14M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.47M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.66M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.45M | – |
| Q4 FY2019 | Dec 28, 2019 | -$7.25M | – |
| Q3 FY2019 | Sep 28, 2019 | -$5.63M | – |
| Q2 FY2019 | Jun 29, 2019 | -$12.31M | – |
| Q1 FY2019 | Mar 30, 2019 | -$7.27M | – |
| Q4 FY2018 | Dec 29, 2018 | -$6.25M | – |
| Q3 FY2018 | Sep 29, 2018 | -$6.31M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.47M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.37M | – |
See a number that looks wrong?